Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 4, 2025
Impact of Coronary Sinus Reducer on Angina Symptoms in Patients With Myocardial Ischemia Without Obstructive Coronary Artery DiseaseFrancesco Giannini, Francesco Ponticelli, Maayan Konigstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)Jiro Aoki, Andrew T L Ong, Alexandre Abizaid, et al.
European Heart Journal|September 8, 2005
In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activityRob Krams, Stefan Verheye, Luc C A van Damme, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary interventionJohn A McPherson, Akiko Maehara, Giora Weisz, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 25, 2019
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patientsGuglielmo Gallone, Patrizio Armeni, Stefan Verheye, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2025
Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and SirolimusStefan Verheye, Bert Ferdinande, Johan Bennett, et al.
Circulation. Cardiovascular Interventions|November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesionsJohn A Ormiston, Alexandre Abizaid, John Spertus, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
Pageof 17